Form 4 for GH Guardant Health, Inc.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-02 · accession 0001576280-24-000098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-06 | 2024-05-02 | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $4.18 | +283.8K | 2.19M | +15% | +$1.19M |
| D | 2024-05-06 | 2024-05-02 | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | -283.8K | 283.8K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | M | A | 283,830 | $4.18 | 2,193,127 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-02 | M | D | 283,830 | $0.00 | 283,829 | D | $4.18 · — to 2027-07-14 | 283,830 Common Stock | (F1) The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017. |